Staar Surgical Co (STAA)
Staar Surgical Co (STAA) is a global provider of minimally invasive ophthalmic surgical products, specializing in designing, manufacturing, and marketing advanced implantable lenses and related instruments. The company focuses on solutions for refractive and cataract surgeries, aiming to improve visual outcomes for patients.
Company News
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches related to recent corporate sales involving STAAR Surgical, Guess?, and Semler Scientific.
Halper Sadeh LLC is investigating potential securities law violations related to the mergers of Staar Surgical and CyberArk Software, encouraging shareholders to explore their legal rights and options.
STAAR Surgical reported Q2 FY2025 earnings with revenue of $44.3 million, exceeding analyst expectations despite significant revenue decline in China. The company is focusing on international markets and restructuring operations to manage challenges.
Staar Surgical (STAA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.